Multiple genetic changes are required for efficient immortalization of different subtypes of normal human mammary epithelial cells

Sarah B. Ratsch, Qingshen Gao, Seetha Srinivasan, David E. Wazer, Vimla Band

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Breast cancer is the second leading cause of cancer-related deaths of women in the U.S. About 180,000 new cases of breast cancer are diagnosed each year, a quarter of them fatal. Early detection is the key to the survival of these patients. However, there are no molecular markers to detect breast cancer at very early stages. A hurdle in understanding the early molecular changes in breast cancer has been the difficulty in establishing premalignant lesions and primary breast tumors as in vitro cell cultures. Normal epithelial cells grow for a finite life span and then senesce. Immortalization is defined by continuous growth of otherwise senescing cells and is believed to represent an early stage in tumor progression. To examine these early stages, we and others have developed in vitro models of mammary epithelial cell immortalization. These models have been extremely important in understanding the role of various tumor suppressor pathways that maintain the normal phenotypes of mammary epithelial cells. In this paper, we describe the establishment of these models and their relevance to understanding the molecular changes that occur in early breast cancer. These models have helped to identify molecular changes that occur in early breast cancers and appear to be well suited to identify novel markers for early diagnosis of breast cancer.

Original languageEnglish (US)
Pages (from-to)143-150
Number of pages8
JournalRadiation Research
Volume155
Issue number1
DOIs
StatePublished - Jan 2001

Fingerprint

breast
breast neoplasms
breasts
Breast
epithelial cells
cancer
Epithelial Cells
Breast Neoplasms
tumors
markers
neoplasms
suppressors
life span
Neoplasms
phenotype
early diagnosis
Early Detection of Cancer
death
progressions
lesions (animal)

ASJC Scopus subject areas

  • Biophysics
  • Radiation
  • Radiology Nuclear Medicine and imaging

Cite this

Multiple genetic changes are required for efficient immortalization of different subtypes of normal human mammary epithelial cells. / Ratsch, Sarah B.; Gao, Qingshen; Srinivasan, Seetha; Wazer, David E.; Band, Vimla.

In: Radiation Research, Vol. 155, No. 1, 01.2001, p. 143-150.

Research output: Contribution to journalArticle

Ratsch, Sarah B. ; Gao, Qingshen ; Srinivasan, Seetha ; Wazer, David E. ; Band, Vimla. / Multiple genetic changes are required for efficient immortalization of different subtypes of normal human mammary epithelial cells. In: Radiation Research. 2001 ; Vol. 155, No. 1. pp. 143-150.
@article{7919adad95134e559a567690576b8815,
title = "Multiple genetic changes are required for efficient immortalization of different subtypes of normal human mammary epithelial cells",
abstract = "Breast cancer is the second leading cause of cancer-related deaths of women in the U.S. About 180,000 new cases of breast cancer are diagnosed each year, a quarter of them fatal. Early detection is the key to the survival of these patients. However, there are no molecular markers to detect breast cancer at very early stages. A hurdle in understanding the early molecular changes in breast cancer has been the difficulty in establishing premalignant lesions and primary breast tumors as in vitro cell cultures. Normal epithelial cells grow for a finite life span and then senesce. Immortalization is defined by continuous growth of otherwise senescing cells and is believed to represent an early stage in tumor progression. To examine these early stages, we and others have developed in vitro models of mammary epithelial cell immortalization. These models have been extremely important in understanding the role of various tumor suppressor pathways that maintain the normal phenotypes of mammary epithelial cells. In this paper, we describe the establishment of these models and their relevance to understanding the molecular changes that occur in early breast cancer. These models have helped to identify molecular changes that occur in early breast cancers and appear to be well suited to identify novel markers for early diagnosis of breast cancer.",
author = "Ratsch, {Sarah B.} and Qingshen Gao and Seetha Srinivasan and Wazer, {David E.} and Vimla Band",
year = "2001",
month = "1",
doi = "10.1667/0033-7587(2001)155[0143:MGCARF]2.0.CO;2",
language = "English (US)",
volume = "155",
pages = "143--150",
journal = "Radiation Research",
issn = "0033-7587",
publisher = "Radiation Research Society",
number = "1",

}

TY - JOUR

T1 - Multiple genetic changes are required for efficient immortalization of different subtypes of normal human mammary epithelial cells

AU - Ratsch, Sarah B.

AU - Gao, Qingshen

AU - Srinivasan, Seetha

AU - Wazer, David E.

AU - Band, Vimla

PY - 2001/1

Y1 - 2001/1

N2 - Breast cancer is the second leading cause of cancer-related deaths of women in the U.S. About 180,000 new cases of breast cancer are diagnosed each year, a quarter of them fatal. Early detection is the key to the survival of these patients. However, there are no molecular markers to detect breast cancer at very early stages. A hurdle in understanding the early molecular changes in breast cancer has been the difficulty in establishing premalignant lesions and primary breast tumors as in vitro cell cultures. Normal epithelial cells grow for a finite life span and then senesce. Immortalization is defined by continuous growth of otherwise senescing cells and is believed to represent an early stage in tumor progression. To examine these early stages, we and others have developed in vitro models of mammary epithelial cell immortalization. These models have been extremely important in understanding the role of various tumor suppressor pathways that maintain the normal phenotypes of mammary epithelial cells. In this paper, we describe the establishment of these models and their relevance to understanding the molecular changes that occur in early breast cancer. These models have helped to identify molecular changes that occur in early breast cancers and appear to be well suited to identify novel markers for early diagnosis of breast cancer.

AB - Breast cancer is the second leading cause of cancer-related deaths of women in the U.S. About 180,000 new cases of breast cancer are diagnosed each year, a quarter of them fatal. Early detection is the key to the survival of these patients. However, there are no molecular markers to detect breast cancer at very early stages. A hurdle in understanding the early molecular changes in breast cancer has been the difficulty in establishing premalignant lesions and primary breast tumors as in vitro cell cultures. Normal epithelial cells grow for a finite life span and then senesce. Immortalization is defined by continuous growth of otherwise senescing cells and is believed to represent an early stage in tumor progression. To examine these early stages, we and others have developed in vitro models of mammary epithelial cell immortalization. These models have been extremely important in understanding the role of various tumor suppressor pathways that maintain the normal phenotypes of mammary epithelial cells. In this paper, we describe the establishment of these models and their relevance to understanding the molecular changes that occur in early breast cancer. These models have helped to identify molecular changes that occur in early breast cancers and appear to be well suited to identify novel markers for early diagnosis of breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=0035219028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035219028&partnerID=8YFLogxK

U2 - 10.1667/0033-7587(2001)155[0143:MGCARF]2.0.CO;2

DO - 10.1667/0033-7587(2001)155[0143:MGCARF]2.0.CO;2

M3 - Article

C2 - 11121226

AN - SCOPUS:0035219028

VL - 155

SP - 143

EP - 150

JO - Radiation Research

JF - Radiation Research

SN - 0033-7587

IS - 1

ER -